This observation indicates a changing pattern of colorectal cancer occurrence. This change may be a regional one or may be a result of genetic or environmental changes.
We report a case of biphasic synovial sarcoma of the mediastinum, a very rare tumor, in a 12-year-old boy with left-sided chest pain of 3 years duration at presentation. Chest X-ray showed left-sided opacity with loss of cardiac silhouette and the mediastinum deviated to the opposite side. Computed tomography (CT) of thorax showed left-sided posterior mediastinal mass with left-sided pleural effusion and pleural thickening. CT guided fine needle aspiration cytology (FNAC) from the mass reported it as spindle cell variant of adenocarcinoma. Ultrasonography (USG) of the whole abdomen revealed no abnormality. The mediastinal tumor was resected by left thoracotomy and histopathological report confirmed it to be a biphasic synovial sarcoma with capsule invasion at places.
Objective This non-randomized study was conducted to assess and compare the response and safety of true accelerated radiation alone to concomitant chemoradiation in locally advanced squamous cell carcinoma of the uterine cervix. Methods Sixty patients with locally advanced squamous cell carcinoma of the uterine cervix, FIGO Stages (2009) IB2-IIIB were non-randomized to receive six fractions per week of external beam radiation (EBRT) (will be henceforth referred to as Arm A or Study arm or pure accelerated radiation arm) and five fractions per week of EBRT and chemotherapy with inj cisplatin 40 mg/m 2 i.v. every
Introduction: Cancers of head and neck region is one of the most common cancer type found in Indian population. Concomitant chemoradiation is the standard treatment for locally advanced head and neck cancer. Different altered fractionation regime has been tried to optimise the outcome. Aim: To compare the response, treatment outcomes and toxicities between accelerated fractionation and concomitant chemoradiation in locally advanced squamous cell cancer of head and neck region. Materials and Methods: This prospective study was conducted at College of Medicine and Sagore Dutta Hospital, West Bengal, Kolkata, India, from March 2020 to December 2020. The study evaluated total of 45 patients of histologically proved locally advanced Tumour (T) Node (N) Metastasis (M) of T2-4 N1-3 M0 squamous cell carcinoma of head and neck region (larynx, oropharynx, hypopharynx and oral cavity). The patients were divided into two groups- Group A (n=22) and Group B (n=23) according to the treatment decided in each subject based on their clinical details and risk factors. Patients in group A received only radiation with accelerated fractionation with 2 Gray (Gy)/fraction, single fraction/day, 6 days/week. Patients allotted in the group B were treated with external beam radiotherapy in conventional fractionation. Concomitant cisplatin was administered at the dose of 100 mg/m2 of Body Surface Area (BSA) in first, fourth and seventh week of radiation. In both the groups, 66-70 Gy of total dose of radiation was prescribed. Patients were followed-up at monthly interval for first three months and at three monthly intervals thereafter. The collected data was tabulated in Microsoft excel sheet and frequency and percentage analysis was done. The significance between two variables was calculated by two tailed Fisher’s-Exact test. Results: Total of 45 patients (43 males and 2 females) were evaluated. The 22 patients (median age 60 years) were included in group A and 23 patients (median age 58 years) in group B. The median overall treatment time observed was 45 days and 59 days in group A and B. The prolongation of treatment was significantly different in between the both groups (p-value=0.0001). A total of 3 (13.04%) patients of group B and 1 (4.54%) patients of study arm could not complete the prescribed radiation (p-value=0.607). Complete Response (CR) was achieved in 8 (36.36%) patients in group A vs 8 (34.78%) patients in the group B and Partial Response (PR) was achieved in 11 patients (50%) vs 10 patients (43.48% cases) of group A and B respectively. Grade II/III vomiting noted in 10 patients (45.45%) vs 18 patients (78.26% cases) (p=0.03) in group A and B respectively. Grade III mucositis was observed in 16 patients (72.73%) vs 18 patients (78.26%) cases (p-value=0.513) in group A and B respectively. Grade III anaemia was observed in 6 patients (27.27%) in group A while in 15 patients (65.22%) in group B (p-value=0.016). No significant difference in late toxicity could be documented. Conclusion: The response rate with accelerated fractionation is not inferior to concomitant chemoradiation. Accelerated fractionation was tolerated well by patients of the present study.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.